7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-06-30 2020-03-31 2019-12-31 2011-06-30 2010-12-31 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-03-31 2008-12-31 2008-06-30 2008-03-31 
      
    		                           
      assets
    		                           
      current assets
    		                           
      cash and cash equivalents
    		39,990,827 27,942,421 28,598,445 29,235,892 28,204,016 28,051,303 28,899,997 31,284,501 29,268,074 28,226,863 24,747,613 16,133,652 13,855,982 15,236,151 17,056,313 16,334,353 17,958,989 1,294,332 3,569,526 3,077,451 2,000,134  3,872,046 4,375,361 10,360,068 5,185,597 4,705,577 
      prepaid expenses and other current assets
    		324,378 401,859 207,063 252,403 355,619 393,437 115,264 305,919 409,339 558,777 113,452 247,211 389,461 637,651 254,652 344,652 47,371           
      total current assets
    		40,315,205 28,344,280 28,805,508 29,488,295 28,559,635 28,444,740 29,015,261 31,590,420 29,677,413 28,785,640 24,861,065 16,490,863 15,030,443 15,873,802 17,310,965 16,679,005 18,406,360 12,561,560 16,062,392 4,862,508 5,975,064  7,458,859 10,141,670 11,235,583 5,401,728 6,986,389 
      other assets
    		                           
      prepaid project costs and other long-term assets
    		528,805 479,625 483,000 486,375 489,750                       
      trademarks
    		108,865 108,865 108,865 108,865 108,225 108,225 108,225 107,757 107,757 101,583 101,583 101,583 100,217 85,562              
      total assets
    		40,952,875 28,932,770 29,397,373 30,083,535 29,157,610 28,897,965 29,468,486 31,698,177 29,785,170 28,887,223 24,962,648 16,592,446 15,130,660 15,959,364 19,067,471 18,481,912 20,204,844 13,164,015 16,551,782 5,331,853 6,428,004  7,927,391 10,600,889 13,932,635 7,462,128 7,233,978 
      liabilities and stockholders’ equity
    		                           
      current liabilities
    		                           
      accounts payable and accrued liabilities
    		424,585 907,421 486,326 875,639 592,719 575,978 350,331 1,190,386 482,661 452,826 171,521 1,107,865 539,095 634,037 893,938 485,693 350,299 1,477,010 1,634,889 1,546,336 1,575,718  2,081,323 3,542,581 3,010,118 2,799,489 2,645,888 
      total current liabilities
    		424,585 907,421 486,326 875,639 592,719 575,978 350,331 1,190,386 482,661 452,826 171,521 1,107,865 1,214,095 634,037 893,938 485,693 350,299        6,280,118 2,812,680 3,138,983 
      commitments and contingencies - note 5
    		                           
      stockholders’ equity
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at december 31, 2024 and 2023
    		                           
      common stock
    		18,784 14,190 13,698 12,934 12,485 12,126 11,900 11,540 11,009 10,589 9,759 7,209 6,595 6,591 3,809 3,364 3,252 12,363 12,334 10,308 10,168  10,154 301,842 301,395 299,395 299,334 
      additional paid-in capital
    		204,694,348 183,228,519 181,295,125 179,222,724 176,740,340 174,825,571 173,595,385 173,077,225 169,834,944 167,464,610 161,772,641 150,163,990 146,684,313 146,482,966 136,647,267 134,338,275 133,932,615           
      accumulated deficit
    		-164,184,842 -155,217,360 -152,397,776 -150,027,762 -148,187,934 -146,515,710 -144,489,130 -142,580,974 -140,543,444 -139,040,802 -136,991,273 -134,689,948 -132,777,693 -131,167,596 -118,480,938 -116,348,832 -114,084,746    -50,407,044  -46,646,308  -39,563,035 -40,415,637  
      total stockholders’ equity
    		40,528,290 28,025,349 28,911,047 29,207,896 28,564,891 28,321,987 29,118,155 30,507,791  28,434,397 24,791,127 15,484,581   18,173,533 17,996,219            
      total liabilities and stockholders’ equity
    		40,952,875 28,932,770 29,397,373 30,083,535 29,157,610 28,897,965 29,468,486 31,698,177  28,887,223 24,962,648 16,592,446   19,067,471 18,481,912            
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at march 31, 2024 and december 31, 2023
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at december 31, 2023 and 2022
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at september 30, 2023 and december 31, 2022
    		                           
      the accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at june 30, 2023 and december 31, 2022
    		                           
      prepaid project costs
    		     345,000 345,000                     
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at march 31, 2023 and december 31, 2022
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at december 31, 2022 and 2021
    		                           
      commitments and contingencies
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at september 30, 2022 and december 31, 2021
    		                           
      liabilities and stockholders' equity
    		                           
      stockholders' equity
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares, 0 shares issued and outstanding at june 30, 2022 and december 31, 2021
    		                           
      total stockholders' equity
    		        29,302,509    13,916,565 15,325,327   19,854,545 11,108,605 14,916,893 3,572,217 4,852,286  5,846,068 7,058,308 7,652,517 4,649,448 4,094,995 
      total liabilities and stockholders' equity
    		        29,785,170    15,130,660 15,959,364   20,204,844 13,164,015 16,551,782 5,331,853 6,428,004  7,927,391 10,600,889 13,932,635 7,462,128 7,233,978 
      commitments and contingencies - note 4
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares
    		                           
      accrued legal settlement costs
    		            675,000               
      convertible series a preferred shares, 0 and 699,878 shares issued and outstanding at december 31, 2021 and 2020, respectively
    		                           
      convertible series b preferred shares, 0 and 2,666,667 shares issued and outstanding at december 31, 2021 and 2020
    		                           
      other receivables
    		           110,000 785,000               
      preferred stock, 0.001par value, 10,000,000authorized shares
    		                           
      convertible series a preferred shares,663,767shares and 699,878 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively
    		           663                
      convertible series b preferred shares, 2,666,667 shares issued and outstanding at september 30, 2021 and december 31, 2020
    		           2,667                
      convertible series a preferred shares, 683,852 shares and 699,878 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively
    		            683               
      convertible series b preferred shares, 2,666,667 shares issued and outstanding at june 30, 2021 and december 31, 2020
    		            2,667               
      convertible series a preferred shares, 699,878 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively
    		             699              
      convertible series b preferred shares, 2,666,667 shares issued and outstanding at march 31, 2021 and december 31, 2020
    		             2,667              
      other receivable from joint venture
    		                400,000           
      patent costs
    		              1,756,506 1,802,907 1,798,484      241,845     
      commitments and contingencies –
    		                           
      preferred stock, 0.001 par value, 10,000,000 authorized shares:
    		                           
      convertible series a preferred shares, 728,816 and 757,770 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively
    		              728             
      convertible series b preferred shares, 2,666,667 issued and outstanding at june 30, 2020 and december 31, 2019,
    		              2,667             
      convertible series a preferred shares, 745,896 and 757,770 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively
    		               745            
      convertible series b preferred shares, 2,666,667 issued and outstanding at march 31, 2020 and december 31, 2019,
    		               2,667            
      total other assets
    		                1,798,484 542,627 410,047 385,202 362,332  367,393 357,102 2,485,771 2,033,191 219,924 
      investee losses in excess of investment
    		                           
      commitments and contingencies - note 6
    		                           
      convertible series a preferred shares, 757,770 shares and 813,624 shares issued and outstanding at december 31, 2019 and 2018, respectively
    		                757           
      convertible series b preferred shares, 2,666,667 shares issued and outstanding at december 31, 2019 and 2018
    		                2,667           
      marketable securities
    		                 8,613,011 10,429,252         
      restricted cash
    		                 551,190 263,619 263,300 652,174  651,409 650,000    
      accounts receivable - project revenue and reimbursable project costs
    		                 1,290,392 1,271,360 1,132,656 2,647,233  2,070,121 4,319,212    
      prepaid expenses & other current assets
    		                 812,635 528,635 389,101 675,523  865,283 797,097 115,586 216,131 232,158 
      property, plant and equipment -net
    		                 59,828          
      patent costs - net
    		                 422,141 289,561 264,716 241,845   234,277 217,875 217,875  
      security deposits
    		                 120,486 120,486 120,486 120,487  125,548 122,825 140,467 140,467 2,049 
      deferred revenue
    		                 578,400  213,300     3,270,000   
      total liabilities
    		                 2,055,410 1,634,889 1,759,636 1,575,718  2,081,323 3,542,581 6,280,118 2,812,680 3,138,983 
      preferred stock, 0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding
    		                           
      additional paid in capital - stock and stock equivalents
    		                 70,098,180 68,917,377 56,539,091 54,836,265  52,996,913 49,902,488 46,744,676 44,530,174 43,156,026 
      deficit
    		                 -59,087,438 -54,082,318 -52,410,629    -43,012,435   -39,418,507 
      common stock reserved for issuance, 19,226 shares and 6,451 shares at june 30, 2011 and december 31, 2010, respectively
    		                 85,500          
      property plant and equipment -net
    		                  79,343 84,143 90,608  101,139 102,117 211,281 27,209  
      liabilities and stockholders equity
    		                           
      common stock reserved for issuance, 10,087 shares and 5,721 shares at september 30, 2010 and december 31, 2009, respectively
    		                  69,500         
      common stock reserved for issuance, 4,204 shares and 5,721 shares at june 30, 2010 and december 31, 2009, respectively
    		                   34,750        
      deferred stock compensation
    		                   -601,303 -721,367  -548,941 -168,587 -409,168 -417,485 -430,278 
      common stock reserved for issuance, 135,318 and 5,721 shares at march 31, 2010 and december 31, 2009, respectively
    		                    1,134,264       
      common stock reserved for issuance, 5,721 shares and 16,135 shares (restated for reverse stock split of 1 for 30, prior to reverse stock split was 484,055 shares) at december 31, 2009 and 2008, respectively
    		                           
      common stock reserved for issuance, 3,869 shares and 16,135 shares (restated for reverse stock split of 1 to 30) at september 30, 2009 and december 31, 2008, respectively
    		                      34,250     
      common stock reserved for issuance, 152,174 shares and 484,055 shares at march 31, 2009 and december 31, 2008, respectively
    		                       35,000    
      accounts receivable - reimbursable project costs
    		                        759,929   
      deferred project costs
    		                          51,729 
      marketable securities - available for sale
    		                        2,127,429 1,674,849 1,996,925 
      current portion long term debt
    		                           
      customer deposit and other current liabilities
    		                         13,191 493,095 
      notes payable - long term
    		                           
      common stock reserved for issuance, 484,055 shares and 2,000,000 shares at september 30, 2008 and december 31, 2007, respectively
    		                        114,787   
      accumulated other comprehensive income
    		                        463,862 26,628 -101,580 
      common stock reserved for issuance, 2,127,626 shares and 2,000,000 shares at june 30, 2008 and december 31, 2007, respectively
    		                         626,373  
      property plant and equipment –net
    		                          27,665 
      patent costs – net
    		                          217,875 
      preferred stock, -.001 par value, 50,000,000 authorized shares, no shares issued and outstanding
    		                           
      common stock reserved for issuance, 2,000,000 shares at march 31, 2008 and december 31, 2007
    		                          590,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.